Endocrine disrupters are exogenous substances which can influence endocrine function in humans and animals, and a number of these chemicals, termed "xenoestrogens", have estrogenic activity. Artificial xenoestrogens include the alkylphenols, nonylphenol and octylphenol, and bisphenol A. 2, 3) Alkylphenol polyethoxylates are widely used as detergents, emulsifiers, and wetting agents in industry. In the environment, nonylphenol occurs predominantly as a degradation product of nonylphenol ethoxylate.
Alkylphenol polyethoxylates are widely used as detergents, emulsifiers, and wetting agents in industry. In the environment, nonylphenol occurs predominantly as a degradation product of nonylphenol ethoxylate. 4) Cytochrome P450s (CYP) comprise a superfamily of enzymes that catalyze the oxidation of a wide variety of xenobiotic chemicals including drugs and carcinogens, and steroids including sex hormones. [5] [6] [7] Lee et al. 8) reported that the metabolism of nonylphenol by rat hepatic microsomes was induced by phenobarbital; the activity was inhibited by 4-amino-2,6-dinitro-1-t-butylxylene, a specific CYP2B inhibitor, and that human CYP2B6 metabolized nonylphenol. Additionally, nonylphenol inhibited progesterone 6b-hydroxylase activity and 7-ethoxyresorufin O-deethylase activity by hepatic microsomes from dexamethazone-and b-naphthoflavone-treated rats, respectively. 9, 10) However, there are no reports describing the effect of nonylphenol on human hepatic CYP-mediated drug-metabolizing activity.
CYP17 is found in the endoplasmic reticulum of the adrenal cortex and gonads, and mediates both 17a-hydroxylase and 17,20-lyase reactions of pregnenolone and progesterone, thus being involved in the biosynthesis of glucocorticoids and sex hormones.
11) Therefore, endocrine disrupters (sex hormone-like compounds) may affect the activity of CYP17.
Recently the heterologous expression systems for human CYPs have been developed in Escherichia coli, in the yeast Saccharomyces cerevisiae, and in human Hep G2 cells, and these genetic technologies have been shown to be very useful in determining the metabolism of xenobiotics by different CYPs. [12] [13] [14] We reported that the aminopyrine N-demethylation process is metabolized by most of the human hepatic CYPs measured, 15) indicating that this is useful to investigate the effect of inhibitors on human hepatic CYPs.
16) Additionally, bisphenol A exhibited a noncompetitive-type inhibition of aminopyrine N-demethylation by CYP2C8, a mixed-type inhibition of S-mephenytoin 4Ј-hydroxylation by CYP2C19, and a competitive-type inhibition of progesterone 17a-hydroxylation by CYP17 with K i values of 97, 113, and 71 mM, respectively. 16, 17) In the present study, we investigated the inhibitory effect of nonylphenol on hepatic CYPs and steroidogenic CYP17 using the cDNA-expressed P450s.
MATERIALS AND METHODS
Materials n-Nonylphenol, aminopyrine, hydrocortisone acetate and human NADPH-cytochrome P450 reductase (fp 2 ) were purchased from Wako Pure Chemical Industries, Ltd. Estrone, progesterone and 17a-hydroxyprogesterone were obtained from Sigma Chemical Co. 4Ј-Hydroxydiclofenac, S-mephenytoin and 4Ј-hydroxymephenytoin were purchased from Sumika Chemical Analysis Service, Ltd., and diclofenac was from Ultrafine Chemicals. All other reagents were of the highest purity commercially available.
Expression of Human CYPs and Preparation of Microsomes Expression of human hepatic CYPs in recombinant
Saccharomyces cerevisiae and CYP17 in Escherichia coli, and preparation of microsomal and membrane fractions, respectively, from the cells were carried out according to the methods described previously. 7, 18, 19) The contents of P450s were determined as described by Omura and Sato. 20) Assay of Aminopyrine N-Demethylase Activity Aminopyrine N-demethylase activity was measured by the method described. 18) For standard incubation, the final reaction mixture (0.5 ml) contained yeast microsomes (50 pmol CYP), 0.4 or 2 mM aminopyrine, 1 mM NADPH, and 100 mM TrisHCl buffer (pH 7.5). After a 3 min preincubation at 37°C, the reaction was started by adding NADPH. Incubation was carried out at 37°C for 5 min and the reaction was stopped by the addition of 0.25 ml of 20% trichloroacetic acid. Aminopyrine N-demethylase activity was determined by the estimation of formaldehyde production using the Nash reagent.
21)

Assay of Diclofenac 4-Hydroxylase Activity
The incubation mixture consisted of yeast microsomes (3 pmol CYP2C9), 2-20 mM Diclofenac, 1 mM NADPH, and 100 mM Tris-HCl buffer (pH 7.5) in a final volume of 0.5 ml. After a 2 min preincubation at 37°C, the reaction was started by adding NADPH. Incubation was carried out at 37°C for 3 min and the reaction was terminated by the addition of 3 ml of ethyl acetate, and 50 ml of 100 mM estrone was added as an internal standard. After ethyl acetate extraction, the organic phase (2.5 ml) was evaporated under nitrogen, the residue was dissolved in 200 ml of the HPLC mobile phase and analyzed by HPLC. The HPLC system consisted of an L-7100 pump, an L-7400 UV-detector set at 282 nm, and a D-7500 integrator (Hitachi). A column (4.6ϫ250 mm) packed with Cosmosil 5C18-AR-II (Nacalai Tesque) was used. The mobile phase consisted of 0.01% triethylamine in 0.75 mM phosphoric acid/acetonitrile (55 : 45), and the flow rate was 1 ml/min.
Assay of S-Mephenytoin 4-Hydroxylase Activity SMephenytoin 4Ј-hydroxylase activity was measured by the method described previously. 17) For standard incubation, the final reaction mixture (0.5 ml) contained yeast microsomes (50 pmol CYP), 20-100 mM S-mephenytoin, 1 mM NADPH, and 100 mM Tris-HCl buffer (pH 7.5). After a 2 min preincubation at 37°C, the reaction was started by adding NADPH. Incubation was carried out at 37°C for 5 min and the reaction was terminated by the addition of 3 ml of ethyl acetate, and 50 ml of 40 mM phenobarbital was added as an internal standard. After ethyl acetate extraction, the organic phase (2.5 ml) was evaporated under nitrogen, the residue was dissolved in 200 ml of the HPLC mobile phase and analyzed by HPLC. The same HPLC system and column as described above were used except that the UV-detector was set at 224 nm. The mobile phase consisted of 7.5 mM phosphoric acid/acetonitrile (80 : 20) , and the flow rate was 1 ml/min.
Assay of Progesterone 17a a-Hydroxylase Activity Progesterone 17a-hydroxylase activity was determined by the methods described previously 7, 17) with minor modification. Briefly, the membrane fraction containing CYP17 (30 pmol) and fp 2 (210 pmol) were preincubated at 37°C for 3 min, and the mixture was brought to 450 ml by addition of 100 mM phosphate buffer (pH 7.4), 10 mM magnesium acetate, and 2-50 mM progesterone. The reaction was started by addition of 50 ml of 10 mM NADPH. Incubation was carried out at 37°C for 20 min and the reaction was terminated by the addition of 2 ml of ethyl acetate, and 50 ml of 100 mM hydrocortisone acetate was added as an internal standard. After ethyl acetate extraction, the organic phase (1.5 ml) was evaporated under nitrogen, the residue was dissolved in 200 ml of the HPLC mobile phase and analyzed by HPLC. The same HPLC system and column as described above were used except that the UV-detector was set at 240 nm. The mobile phase consisted of methanol/acetonitrile/water (55 : 10 : 35), and the flow rate was 0.75 ml/min.
Kinetic Analysis V max and K m values for diclofenac 4Ј-hydroxylase, S-mephenytoin 4Ј-hydroxylase, and progesterone 17a-hydroxylase activities were determined by fitting to Michaelis-Menten kinetics by Lineweaver-Burk plots, and the inhibition constants (K i values) were estimated from a plot of K m app as a function of increasing inhibitor concentrations.
RESULTS
The inhibitory effect of nonylphenol (1 mM) on the Ndemethylation of aminopyrine was investigated on ten forms of human hepatic CYPs (Fig. 1) . Aminopyrine N-demethylation was dependent on CYP content and incubation time and the inhibition study was conducted under optimal conditions of CYP contents (50 pmol/reaction) and incubation time (5 min). 15) Additionally, because the K m values for the Ndemethylation by CYP1A2, 2C8, 2C19, and 2D6 ranged between 0.31 and 5.3 mM, 15) the inhibition was determined at 0.4 and 2 mM as substrate concentrations. Aminopyrine Ndemethylation determined at 2 mM as a substrate concentration (Fig. 1A) was catalyzed most efficiently by CYP2C19. CYP2A6, CYP2B6, CYP2C8 and CYP2D6 showed 25-59% of the activity by CYP2C19. CYP1A1, CYP1A2, CYP2C9, CYP2C18, and CYP3A4 could catalyze the Ndemethylation reaction, but much lower than CYP2C19 (less than18%). Nonylphenol (1 mM) most efficiently inhibited aminopyrine N-demethylase activities of CYP2C9 and CYP2C19, by 61% and 59%, respectively, followed by, CYP2D6, CYP1A2, CYP2C18 and CYP2C8 (46-51%), whereas inhibition of the activities by CYP1A1, CYP2A6, CYP2B6, and CYP3A4 was less than 27%. When deter- mined at 0.4 mM substrate concentration (Fig. 1B) , aminopyrine N-demethylase activities by CYP2C19, CYP2B6, CYP2A6, and CYP2D6 were detected, and nonylphenol most efficiently inhibited the activity by CYP2C19 by 63%, whereas inhibition of the activities by CYP2A6, CYP2B6, and CYP2D6 was less than 40%.
Nonylphenol inhibited most efficiently the aminopyrine N-demethylation by CYP2C9 and CYP2C19. It is reported that diclofenac 4Ј-hydroxylation and S-mephenytoin 4Ј-hydroxylation are predominantly catalyzed by CYP2C9 and CYP2C19, respectively. [22] [23] [24] Therefore, we investigated the inhibitory effects of nonylphenol on CYP2C9-mediated diclofenac 4Ј-hydroxylase and CYP2C19-mediated S-mephenytoin 4Ј-hydroxylase activities (Figs. 2, 3 ). In the absence of nonylphenol, K m and V max values for diclofenac 4Ј-hydroxylation by CYP2C9 were 5.70 mM and 98.2 nmol/min/nmol CYP, respectively. In the presence of increasing nonylphenol concentrations, a concentration dependent inhibition of diclofenac 4Ј-hydroxylation was characterized by an increasing K m value, whereas V max value remained constant (Fig. 2) . This is consistent with a competitive-type inhibition of diclofenac 4Ј-hydroxylation by nonylphenol, and the K i value for nonylphenol was calculated to be 5.3 mM. On the other hand, K m and V max values for S-mephenytoin 4Ј-hydroxylase activity by CYP2C19 were 30.8 mM and 29.1 nmol/min/nmol CYP, respectively, and nonylphenol exhibited the competitive inhibition; the K i value for nonylphenol was calculated to be 37 mM (Fig. 3) .
The inhibitory effect of nonylphenol on progesterone 17a-hydroxylation by CYP17 was investigated in the concentration ranging from 200 to 500 mM (Fig. 4) . In the absence of nonylphenol, K m and V max values for progesterone 17a-hydroxylation by CYP17 were 4.26 mM and 3.60 nmol/min/ nmol CYP, respectively. In the presence of increasing nonylphenol concentrations, a concentration dependent inhibition of progesterone 17a-hydroxylation was characterized by an increasing K m value, whereas V max value remained constant. This is consistent with a competitive-type inhibition of progesterone 17a-hydroxylation by nonylphenol, and the K i value for nonylphenol was calculated to be 62 mM.
DISCUSSION
Lee et al. 9) reported that nonylphenol noncompetitively inhibited progesterone 6b-hydroxylase activity (CYP3A) by hepatic microsomes from dexamethazone-treated rats, and that did not inhibit 17a-hydroxylation of progesterone but inhibited 16a-hydroxylation (CYP2C). Additionally, they reported that nonylphenol competitively inhibited 7-ethoxyresorufin O-deethylase activity (CYP1A) by hepatic microsomes from b-naphthoflavone-treated rats. 10) We investigated the effect of nonylphenol on the human CYP activities using aminopyrine as a substrate, because most of the CYPs showed the aminopyrine N-demethylase activity.
18) Nonylphenol (1 mM) inhibited aminopyrine N-demethylation by CYP1A2, CYP2C8 CYP2C9, CYP2C18, CYP2C19 and CYP2D6 more than 49%, whereas the inhibition of the activities by CYP1A1 and CYP3A4 was less than 27% (Fig. 1) . Additionally, nonylphenol exhibited a competitive-type inhibition of diclofenac 4Ј-hydroxylaytion by CYP2C9 and S-mephenytoin 4Ј-hydroxylation by CYP2C19 with K i values of 5.3 and 37 mM, respectively (Figs. 2, 3) . Our results indicated that nonylphenol could inhibit the drug-metabolizing activities by human hepatic CYPs as well as those in rats, especially CYP1A and CYP2C. 9, 10) We have reported that bisphenol A exhibited a noncompetitive-type inhibition of aminopyrine N-demethylation by CYP2C8, a mixed-type inhibition of S-mephenytoin 4Ј-hydroxylation by CYP2C19, and a competitive-type inhibition of progesterone 17a-hydroxylation by CYP17 with K i values of 97, 113, and 71 mM, respectively. 16, 17) The K i values of nonylphenol on diclofenac 4Ј-hydroxylaytion by CYP2C9, Smephenytoin 4Ј-hydroxylation by CYP2C19 and progesterone 17a-hydroxylation by CYP17 were 5.3 mM, 37 mM and 62 mM, respectively (Figs. 2-4) . Therefore, these results suggest that the inhibition of human CYPs by nonylphenol was at least comparable with those by bisphenol A. However, the metabolism of nonylphenol by human hepatic CYPs and CYP17 is not clear. Additionally, there are few reports on nonylphenol concentrations in plasma, liver or adrenals after dosing in human. To further evaluate potential hazards posed by nonylphenol to human, more information is needed on its exposure and pharmacokinetics.
In summary, we showed that nonylphenol inhibited human hepatic CYPs, especially CYP2C9 and CYP2C19, and exhibited a competitive inhibition for progesterone 17a-hydroxylation by CYP17.
